166 results on '"González-Cao, María"'
Search Results
2. Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study
3. Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab
4. Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
5. KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
6. Liquid biopsy in detecting early non-small cell lung cancer
7. Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
8. Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
9. Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis.
10. KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
11. Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial.
12. Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma
13. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
14. Biological insights in non-small cell lung cancer
15. The role of biomarkers in stage III non-small cell lung cancer
16. Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
17. Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma
18. Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patients
19. Ablating lung cancer, knowing the tumor better
20. Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination
21. Kisspeptins and norepinephrine regulate different G-protein-coupled receptor signaling pathways
22. Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer.
23. Location of EGFR exon 20 insertions matters
24. Abstract 1424: Prospective validation of a mRNA signature in plasma for the diagnosis of early stage lung cancer
25. Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
26. Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial
27. Correlatos entre tipos de personalidad y subtipos moleculares de cáncer de mama
28. Rasgos de personalidad y estrés percibido según subtipos moleculares de cáncer de mama
29. COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study
30. BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
31. Surgical Management of Vulvar Melanoma: A Case Series
32. Abstract 2606: A nCounter-Based mRNA signature in plasma associates with localized non-small cell lung cancer
33. Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial
34. Advances in cutaneous melanoma
35. Evaluation of multiple serum markers in advanced melanoma
36. El tratamiento del melanoma: una perspectiva histórica
37. Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection
38. Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection
39. Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patients
40. Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer
41. PD.02.02 Lung TS: A New 6-Gene Signature for Prediction of Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Patients
42. Perioperative high-dose-rate brachytherapy in soft tissue sarcomas of the extremity and superficial trunk in adults: Initial results of a pilot study
43. Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions
44. Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancers.
45. Other targeted drugs in melanoma
46. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
47. A randomized phase II study of vemurafenib plus cobimetinib continuous versus intermittent in previously untreated BRAF V600-mutation positive patients with unresectable locally advanced or metastatic melanoma.
48. P2.01-008 SiRe Next Generation Sequencing Panel: Effective Diagnostic Tool for Circulating Free DNA Analysis
49. Advances in immunotherapy for treatment of lung cancer
50. Focused issue on 'Melanoma'
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.